Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative Disease Collaboration
Capsida Biotherapeutics ("Capsida") today announced that AbbVie has exercised an option for the first neurodegenerative ...
FierceBiotech4d
AbbVie exercises first $40M option to advance Capsida-partnered CNS gene therapy
Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...
Mena FN4d
Capsida Announces Abbvie Opt-In For First Genetic Medicine Program From Neurodegenerative Disease Collaboration
Capsida Biotherapeutics ("Capsida") today announced that AbbVie has exercised an option for the first neurodegenerative disease program under their ongoing collaboration. Capsida will receive a $ ...
Yahoo Finance23d
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
THOUSAND OAKS, Calif., Dec. 19, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida"), leader in next-generation IV-administered central nervous system (CNS) gene therapies, today announced it will ...
Morningstar23d
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
THOUSAND OAKS, Calif., Dec. 19, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida"), leader in next-generation IV-administered central nervous system (CNS) gene therapies, today announced it ...
The Victoria Advocate23d
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Capsida Biotherapeutics is a fully integrated gene therapy company with a central nervous system (CNS) pipeline consisting of disease modifying and potentially curative treatments for rare and ...